gene_symbol
CD3E
hgnc_id
HGNC:1674
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Cevostamab bridges CD3 on T cells to FCRH5 on myeloma cells, activating T cells to kill FCRH5+ tumor cells via perforin/granzyme-mediated lysis; CD3+ cells are not the targets killed.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05927571
disease_id_num_tar_ref
2326
drug_id_num_tar_ref
6202